This report contains market size and forecasts of Transdermal Skin Patch in global, including the following market information:
Global Transdermal Skin Patch Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global Transdermal Skin Patch Market Sales, 2016-2021, 2022-2027, (K Units)
Global top five Transdermal Skin Patch companies in 2020 (%)
The global Transdermal Skin Patch market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Transdermal Skin Patch manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Transdermal Skin Patch Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Units)
Global Transdermal Skin Patch Market Segment Percentages, By Type, 2020 (%)
Fentanyl Transdermal Skin Patch
Nicotine Transdermal Skin Patch
Clonidine Transdermal Skin Patch
Buprenorphine Transdermal Skin Patch
Global Transdermal Skin Patch Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Units)
Global Transdermal Skin Patch Market Segment Percentages, By Application, 2020 (%)
Relieve Severe Pain
Stop Smoking Cigarettes
Treat an Overactive Bladder
Others
Global Transdermal Skin Patch Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (K Units)
Global Transdermal Skin Patch Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Transdermal Skin Patch revenues in global market, 2016-2021 (Estimated), ($ millions)
Key companies Transdermal Skin Patch revenues share in global market, 2020 (%)
Key companies Transdermal Skin Patch sales in global market, 2016-2021 (Estimated), (K Units)
Key companies Transdermal Skin Patch sales share in global market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
Hisamitsu Pharmaceutical
Novartis
Johnson & Johnson
Teikoku Pharma
Mylan
Actavis
Mundipharma
Henan Lingrui Pharmaceutical
Changzhou Siyao
Rfl Pharmaceutical
Luye Pharma Group Ltd.
Purdue Pharma L.P.
Teva Pharmaceutical Industries Ltd.
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Transdermal Skin Patch Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Transdermal Skin Patch Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Transdermal Skin Patch Overall Market Size
2.1 Global Transdermal Skin Patch Market Size: 2021 VS 2027
2.2 Global Transdermal Skin Patch Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Transdermal Skin Patch Sales (Consumption): 2016-2027
3 Company Landscape
3.1 Top Transdermal Skin Patch Players in Global Market
3.2 Top Global Transdermal Skin Patch Companies Ranked by Revenue
3.3 Global Transdermal Skin Patch Revenue by Companies
3.4 Global Transdermal Skin Patch Sales by Companies
3.5 Global Transdermal Skin Patch Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Transdermal Skin Patch Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Transdermal Skin Patch Product Type
3.8 Tier 1, Tier 2 and Tier 3 Transdermal Skin Patch Players in Global Market
3.8.1 List of Global Tier 1 Transdermal Skin Patch Companies
3.8.2 List of Global Tier 2 and Tier 3 Transdermal Skin Patch Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Transdermal Skin Patch Market Size Markets, 2021 & 2027
4.1.2 Fentanyl Transdermal Skin Patch
4.1.3 Nicotine Transdermal Skin Patch
4.1.4 Clonidine Transdermal Skin Patch
4.1.5 Buprenorphine Transdermal Skin Patch
4.2 By Type - Global Transdermal Skin Patch Revenue & Forecasts
4.2.1 By Type - Global Transdermal Skin Patch Revenue, 2016-2021
4.2.2 By Type - Global Transdermal Skin Patch Revenue, 2022-2027
4.2.3 By Type - Global Transdermal Skin Patch Revenue Market Share, 2016-2027
4.3 By Type - Global Transdermal Skin Patch Sales & Forecasts
4.3.1 By Type - Global Transdermal Skin Patch Sales, 2016-2021
4.3.2 By Type - Global Transdermal Skin Patch Sales, 2022-2027
4.3.3 By Type - Global Transdermal Skin Patch Sales Market Share, 2016-2027
4.4 By Type - Global Transdermal Skin Patch Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Transdermal Skin Patch Market Size, 2021 & 2027
5.1.2 Relieve Severe Pain
5.1.3 Stop Smoking Cigarettes
5.1.4 Treat an Overactive Bladder
5.1.5 Others
5.2 By Application - Global Transdermal Skin Patch Revenue & Forecasts
5.2.1 By Application - Global Transdermal Skin Patch Revenue, 2016-2021
5.2.2 By Application - Global Transdermal Skin Patch Revenue, 2022-2027
5.2.3 By Application - Global Transdermal Skin Patch Revenue Market Share, 2016-2027
5.3 By Application - Global Transdermal Skin Patch Sales & Forecasts
5.3.1 By Application - Global Transdermal Skin Patch Sales, 2016-2021
5.3.2 By Application - Global Transdermal Skin Patch Sales, 2022-2027
5.3.3 By Application - Global Transdermal Skin Patch Sales Market Share, 2016-2027
5.4 By Application - Global Transdermal Skin Patch Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
6.1 By Region - Global Transdermal Skin Patch Market Size, 2021 & 2027
6.2 By Region - Global Transdermal Skin Patch Revenue & Forecasts
6.2.1 By Region - Global Transdermal Skin Patch Revenue, 2016-2021
6.2.2 By Region - Global Transdermal Skin Patch Revenue, 2022-2027
6.2.3 By Region - Global Transdermal Skin Patch Revenue Market Share, 2016-2027
6.3 By Region - Global Transdermal Skin Patch Sales & Forecasts
6.3.1 By Region - Global Transdermal Skin Patch Sales, 2016-2021
6.3.2 By Region - Global Transdermal Skin Patch Sales, 2022-2027
6.3.3 By Region - Global Transdermal Skin Patch Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America Transdermal Skin Patch Revenue, 2016-2027
6.4.2 By Country - North America Transdermal Skin Patch Sales, 2016-2027
6.4.3 US Transdermal Skin Patch Market Size, 2016-2027
6.4.4 Canada Transdermal Skin Patch Market Size, 2016-2027
6.4.5 Mexico Transdermal Skin Patch Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe Transdermal Skin Patch Revenue, 2016-2027
6.5.2 By Country - Europe Transdermal Skin Patch Sales, 2016-2027
6.5.3 Germany Transdermal Skin Patch Market Size, 2016-2027
6.5.4 France Transdermal Skin Patch Market Size, 2016-2027
6.5.5 U.K. Transdermal Skin Patch Market Size, 2016-2027
6.5.6 Italy Transdermal Skin Patch Market Size, 2016-2027
6.5.7 Russia Transdermal Skin Patch Market Size, 2016-2027
6.5.8 Nordic Countries Transdermal Skin Patch Market Size, 2016-2027
6.5.9 Benelux Transdermal Skin Patch Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia Transdermal Skin Patch Revenue, 2016-2027
6.6.2 By Region - Asia Transdermal Skin Patch Sales, 2016-2027
6.6.3 China Transdermal Skin Patch Market Size, 2016-2027
6.6.4 Japan Transdermal Skin Patch Market Size, 2016-2027
6.6.5 South Korea Transdermal Skin Patch Market Size, 2016-2027
6.6.6 Southeast Asia Transdermal Skin Patch Market Size, 2016-2027
6.6.7 India Transdermal Skin Patch Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America Transdermal Skin Patch Revenue, 2016-2027
6.7.2 By Country - South America Transdermal Skin Patch Sales, 2016-2027
6.7.3 Brazil Transdermal Skin Patch Market Size, 2016-2027
6.7.4 Argentina Transdermal Skin Patch Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Transdermal Skin Patch Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa Transdermal Skin Patch Sales, 2016-2027
6.8.3 Turkey Transdermal Skin Patch Market Size, 2016-2027
6.8.4 Israel Transdermal Skin Patch Market Size, 2016-2027
6.8.5 Saudi Arabia Transdermal Skin Patch Market Size, 2016-2027
6.8.6 UAE Transdermal Skin Patch Market Size, 2016-2027
7 Manufacturers & Brands Profiles
7.1 Hisamitsu Pharmaceutical
7.1.1 Hisamitsu Pharmaceutical Corporate Summary
7.1.2 Hisamitsu Pharmaceutical Business Overview
7.1.3 Hisamitsu Pharmaceutical Transdermal Skin Patch Major Product Offerings
7.1.4 Hisamitsu Pharmaceutical Transdermal Skin Patch Sales and Revenue in Global (2016-2021)
7.1.5 Hisamitsu Pharmaceutical Key News
7.2 Novartis
7.2.1 Novartis Corporate Summary
7.2.2 Novartis Business Overview
7.2.3 Novartis Transdermal Skin Patch Major Product Offerings
7.2.4 Novartis Transdermal Skin Patch Sales and Revenue in Global (2016-2021)
7.2.5 Novartis Key News
7.3 Johnson & Johnson
7.3.1 Johnson & Johnson Corporate Summary
7.3.2 Johnson & Johnson Business Overview
7.3.3 Johnson & Johnson Transdermal Skin Patch Major Product Offerings
7.3.4 Johnson & Johnson Transdermal Skin Patch Sales and Revenue in Global (2016-2021)
7.3.5 Johnson & Johnson Key News
7.4 Teikoku Pharma
7.4.1 Teikoku Pharma Corporate Summary
7.4.2 Teikoku Pharma Business Overview
7.4.3 Teikoku Pharma Transdermal Skin Patch Major Product Offerings
7.4.4 Teikoku Pharma Transdermal Skin Patch Sales and Revenue in Global (2016-2021)
7.4.5 Teikoku Pharma Key News
7.5 Mylan
7.5.1 Mylan Corporate Summary
7.5.2 Mylan Business Overview
7.5.3 Mylan Transdermal Skin Patch Major Product Offerings
7.5.4 Mylan Transdermal Skin Patch Sales and Revenue in Global (2016-2021)
7.5.5 Mylan Key News
7.6 Actavis
7.6.1 Actavis Corporate Summary
7.6.2 Actavis Business Overview
7.6.3 Actavis Transdermal Skin Patch Major Product Offerings
7.6.4 Actavis Transdermal Skin Patch Sales and Revenue in Global (2016-2021)
7.6.5 Actavis Key News
7.7 Mundipharma
7.7.1 Mundipharma Corporate Summary
7.7.2 Mundipharma Business Overview
7.7.3 Mundipharma Transdermal Skin Patch Major Product Offerings
7.4.4 Mundipharma Transdermal Skin Patch Sales and Revenue in Global (2016-2021)
7.7.5 Mundipharma Key News
7.8 Henan Lingrui Pharmaceutical
7.8.1 Henan Lingrui Pharmaceutical Corporate Summary
7.8.2 Henan Lingrui Pharmaceutical Business Overview
7.8.3 Henan Lingrui Pharmaceutical Transdermal Skin Patch Major Product Offerings
7.8.4 Henan Lingrui Pharmaceutical Transdermal Skin Patch Sales and Revenue in Global (2016-2021)
7.8.5 Henan Lingrui Pharmaceutical Key News
7.9 Changzhou Siyao
7.9.1 Changzhou Siyao Corporate Summary
7.9.2 Changzhou Siyao Business Overview
7.9.3 Changzhou Siyao Transdermal Skin Patch Major Product Offerings
7.9.4 Changzhou Siyao Transdermal Skin Patch Sales and Revenue in Global (2016-2021)
7.9.5 Changzhou Siyao Key News
7.10 Rfl Pharmaceutical
7.10.1 Rfl Pharmaceutical Corporate Summary
7.10.2 Rfl Pharmaceutical Business Overview
7.10.3 Rfl Pharmaceutical Transdermal Skin Patch Major Product Offerings
7.10.4 Rfl Pharmaceutical Transdermal Skin Patch Sales and Revenue in Global (2016-2021)
7.10.5 Rfl Pharmaceutical Key News
7.11 Luye Pharma Group Ltd.
7.11.1 Luye Pharma Group Ltd. Corporate Summary
7.11.2 Luye Pharma Group Ltd. Transdermal Skin Patch Business Overview
7.11.3 Luye Pharma Group Ltd. Transdermal Skin Patch Major Product Offerings
7.11.4 Luye Pharma Group Ltd. Transdermal Skin Patch Sales and Revenue in Global (2016-2021)
7.11.5 Luye Pharma Group Ltd. Key News
7.12 Purdue Pharma L.P.
7.12.1 Purdue Pharma L.P. Corporate Summary
7.12.2 Purdue Pharma L.P. Transdermal Skin Patch Business Overview
7.12.3 Purdue Pharma L.P. Transdermal Skin Patch Major Product Offerings
7.12.4 Purdue Pharma L.P. Transdermal Skin Patch Sales and Revenue in Global (2016-2021)
7.12.5 Purdue Pharma L.P. Key News
7.13 Teva Pharmaceutical Industries Ltd.
7.13.1 Teva Pharmaceutical Industries Ltd. Corporate Summary
7.13.2 Teva Pharmaceutical Industries Ltd. Transdermal Skin Patch Business Overview
7.13.3 Teva Pharmaceutical Industries Ltd. Transdermal Skin Patch Major Product Offerings
7.13.4 Teva Pharmaceutical Industries Ltd. Transdermal Skin Patch Sales and Revenue in Global (2016-2021)
7.13.5 Teva Pharmaceutical Industries Ltd. Key News
8 Global Transdermal Skin Patch Production Capacity, Analysis
8.1 Global Transdermal Skin Patch Production Capacity, 2016-2027
8.2 Transdermal Skin Patch Production Capacity of Key Manufacturers in Global Market
8.3 Global Transdermal Skin Patch Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Transdermal Skin Patch Supply Chain Analysis
10.1 Transdermal Skin Patch Industry Value Chain
10.2 Transdermal Skin Patch Upstream Market
10.3 Transdermal Skin Patch Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Transdermal Skin Patch Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of Transdermal Skin Patch in Global Market
Table 2. Top Transdermal Skin Patch Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Transdermal Skin Patch Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Transdermal Skin Patch Revenue Share by Companies, 2016-2021
Table 5. Global Transdermal Skin Patch Sales by Companies, (K Units), 2016-2021
Table 6. Global Transdermal Skin Patch Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Transdermal Skin Patch Price (2016-2021) & (USD/Unit)
Table 8. Global Manufacturers Transdermal Skin Patch Product Type
Table 9. List of Global Tier 1 Transdermal Skin Patch Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Transdermal Skin Patch Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type
Hisamitsu Pharmaceutical
Novartis
Johnson & Johnson
Teikoku Pharma
Mylan
Actavis
Mundipharma
Henan Lingrui Pharmaceutical
Changzhou Siyao
Rfl Pharmaceutical
Luye Pharma Group Ltd.
Purdue Pharma L.P.
Teva Pharmaceutical Industries Ltd.